Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
This study is currently recruiting participants.
Verified May 2013 by National Cancer Institute (NCI)
Study NCT01236560
Information provided by National Cancer Institute (NCI)
First Received on November 5, 2010.
Last Updated on May 1, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
